Oracles, Billion

Oracle's $3 Billion Microsoft Deal Twist Adds to a Record Quarter's Darker Undercurrents

Published on 06/17/2026 at 09:37 | Redaktion boerse-global.de

Oracle's stock fell 9% despite record revenue, as massive capex drained cash, Microsoft deal stalled, and OpenAI risk looms.

Oracle Stock Drops 9% on Capex Concerns and OpenAI Concentration Risk
Oracle's $3 Billion Microsoft Deal Twist Adds to a Record Quarter's Darker Undercurrents Illustration mit AI erstellt übermittelt durch boerse-global.de

The market's punishment of Oracle's latest earnings was swift and severe, with shares shedding nearly 9% before settling into a weekly decline of close to 7%. The stock now trades at roughly €162 — a staggering 42% below its 52-week high and 8% beneath the 200-day moving average. At first glance, the sell-off seems baffling. Revenue hit a record $19.2 billion in the fiscal fourth quarter, up 21% year over year, while adjusted earnings per share of $2.03 edged past analyst forecasts. The cloud business expanded by nearly 50%, and the remaining performance obligations — essentially a backlog of committed contracts — swelled to an eye-popping $638 billion, a 363% surge from a year earlier.

Yet those headline numbers mask a deepening anxiety about how Oracle intends to bankroll its aggressive infrastructure build-out. Capital expenditures more than doubled to over $55 billion, driving free cash flow deep into negative territory at minus $23.7 billion. Operating cash flow did improve, climbing 54% to $32 billion, but investors are fixated on the financing hole. The company raised $48 billion through debt and equity last year and plans to tap markets for another $40 billion in the current fiscal year. The message from Wall Street is clear: growth is expensive, and the bill keeps arriving.

Compounding that cash-flow strain is a report that a proposed cloud partnership with Microsoft worth more than $3 billion is teetering. Microsoft had been looking to shift some of its own workloads onto Oracle's public cloud, but the deal has stalled over a missing security clearance. Oracle's public cloud lacks the FedRAMP certification required to handle U.S. government data, and the company has so far resisted retrofitting it, citing the enormous technical cost. A spokesman dismissed the rumor as "incorrect" without offering specifics, while Microsoft has stayed silent. For a business already under pressure to deliver on its cloud promises, any hint of a setback with a major customer like Microsoft amplifies the market's nervousness.

Should investors sell immediately? Or is it worth buying Oracle?

The $638 billion backlog, while impressive, comes with its own concentration risk. Bank of America analysts estimate that more than 50% of that total is tied to a single customer: OpenAI. The AI giant has prepaid for vast GPU capacity, giving Oracle a pipeline of future revenue that the bank expects roughly 12% of to convert into recognized sales in the near term — provided the data centers get built on schedule. That reliance on one partner is a double-edged sword: it makes revenue highly visible but leaves Oracle exposed to any shift in OpenAI's strategy or spending. Meanwhile, the overall cloud business missed analysts' expectations by a hair, and Oracle's own forecast calls for cloud growth to accelerate to around 60% in the first quarter of 2027 — a target that leaves little room for execution hiccups.

Oracle's management has lifted its adjusted earnings outlook to $8.05 per share and maintains a long-term revenue goal of $90 billion. The company's multicloud AI database, which stitches together AWS, Azure and Google Cloud infrastructure, grew 404% in the latest quarter and is hailed as the fastest-growing product in corporate history. But the unit economics are punishing. Analysts expect negative free cash flow to persist for years, with a potential inflection point not coming until around 2030. The market's annualized volatility of nearly 70% reflects deep uncertainty about whether demand can keep pace with the capital drain.

The sell-off has pushed Oracle's valuation to a notable discount relative to its earnings growth. Earnings per share have compounded at 19% annually, while the stock has risen only 13% per year. The average analyst price target stands at $220.25, implying a potential upside of roughly 36% from current levels. Bank of America views the recent rout as noise, pointing to the structural demand for Oracle's database services as enterprises diversify away from single-cloud dependency. Yet with a market cap of about €456 billion, the stock already prices in a good deal of doubt. The gap between today's price and that analyst consensus is effectively what the market is charging for patience — and in this phase of aggressive AI capital deployment, patience is a scarce commodity.

Ad

Oracle Stock: New Analysis - 17 June

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLES | boerse | 69560394 |